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Background: The OPENMinds Primary Care group is a group of European primary care 
physicians (PCPs) with an interest in pain management, formed to improve the understanding 
and management of chronic pain in primary care.
Objective: A survey was conducted to assess the challenges of chronic nonmalignant pain 
(CNMP) management in primary care in Europe, focusing particularly on pain assessment, 
opioid therapy, and educational needs.
Methods: A questionnaire was developed for online use by PCPs in 13 European countries 
(Belgium, Denmark, France, Germany, Ireland, Italy, the Netherlands, Norway, Poland, Portugal, 
Spain, Sweden, and the UK).
Results: A total of 1309 PCPs completed the questionnaire, approximately 100 from each 
country. Most PCPs (84%) perceived CNMP to be one of the most challenging conditions to 
treat, yet a low priority within healthcare systems. Only 48% of PCPs used pain assessment 
tools, and 81% considered chronic pain and its impact on quality of life to be underassessed 
in primary care. PCPs were less confident about prescribing strong opioids for CNMP than 
for use in cancer pain. Most PCPs (84%) considered their initial training on CNMP was not 
comprehensive, with 89% recognizing a need for more education on the topic.
Conclusion: These findings reveal that PCPs in Europe find CNMP a challenge to treat. Areas 
to address with training include underuse of pain assessment tools and lack of confidence in use 
of opioid therapy. Guidelines on CNMP management in primary care would be welcomed. The 
insights gained should provide the basis for future initiatives to support primary care manage-
ment of chronic pain.
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Introduction
It is estimated that 70% of patients with chronic pain are managed in primary care.1 
Chronic pain is a key reason for consulting primary care physicians (PCPs), account-
ing for 22% of presenting conditions,2 with over a third of adult appointments with 
a PCP involving a patient in chronic pain.3 Furthermore, patients with chronic pain 
consult their PCPs five times more frequently than patients without such pain.4 With 
such extensive and regular exposure to the needs of patients with chronic pain, it might 
be expected that PCPs would be highly confident and proficient in its management. 
However, at least 40% of patients with chronic pain treated in a routine practice set-
ting do not achieve adequate pain relief.5 This suggests that chronic pain management 
presents a challenge to many physicians.6
Surveys of PCPs conducted in the USA report considerable frustration and dissat-
isfaction with the management of chronic pain.3,7 These and other surveys conducted 
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in North America identified challenges, including a lack of 
confidence in chronic pain management, concerns about the 
use of opioid analgesia, and dissatisfaction with training.8,9 
Similar challenges may face European PCPs.
With this in mind, the pan-European Opioids and Pain 
European Network of Minds (OPENMinds) Primary Care 
group (OMPC) was formed, to act synergistically with the 
already established OPENMinds group of leading European 
experts who specialize in the research and management of 
pain. The OMPC aims to explore initiatives that enhance 
pain management in primary care in Europe. The first 
initiative of the OMPC was a survey of PCPs to assess the 
challenges of chronic nonmalignant pain (CNMP) manage-
ment in primary care in Europe, focusing particularly on 
pain assessment, opioid therapy, and educational needs. 
The findings should form an evidence base for future 
initiatives.
Materials and methods
Questionnaire development
The OMPC group met in November 2010 and identi-
fied CNMP and opioid analgesia as particular problems 
encountered by PCPs. The OMPC Steering Committee 
developed a questionnaire on chronic pain (pain present 
for at least 3 months, several days per month, and present 
in the last month), as defined by the International Associa-
tion for the Study of Pain (IASP).10 The questionnaire (see 
Supplementary material) was translated into European 
languages that were appropriate for the target countries. 
Back-translation was used to check for the validity of the 
terminology used.
Respondents
The research was conducted online to reach a large number of 
respondents from different countries in a timely and efficient 
manner. An online panel of more than 500,000  physicians 
across Europe was used. From this panel, a sample of 
approximately 100 PCPs was taken from each of 13 European 
countries (Belgium, Denmark, France, Germany, Ireland, Italy, 
the Netherlands, Norway, Poland, Portugal, Spain, Sweden, 
and the UK). The samples were selected to be nationally rep-
resentative in terms of sex, age, and regional distribution. All 
respondents were PCPs (3–45 years of experience) spending 
at least 20 hours each week in direct patient care. Respon-
dents received compensation (within accepted guidelines) for 
their participation. Fieldwork was undertaken in July 2011.
Statistical methods
Responses to each question were collated and analyzed for the 
total group and for subgroups defined by sex, years in prac-
tice, practice size, and country. Responses within subgroups 
were compared using one way analysis of variance (ANOVA), 
followed by the Bonferroni t-test for multiple comparisons 
or by the Student’s t-test when comparing only two groups; 
a P-value , 0.05 was considered statistically significant.
Results
A total of 1309 PCPs completed the questionnaire (Table 1).
Does management of CNMP  
present a challenge to PCPs?
Patients with CNMP were seen as challenging to manage 
by 88% of PCPs, though this view was less likely among 
Table 1 Demographic characteristics of PCPs participating in the survey
Total Males Mean 
years in  
practice
Mean hours per  
week in direct  
patient care
Mean no  
patients seen  
per month
Single PCP  
practice
2–5 PCPs  
in practice
$6 PCPs  
in practice
Part of  
large  
MDT
Total 1309 949 (72%) 19.7 40.5 441.5 391 (30%) 638 (49%) 223 (17%) 57 (4%)
Belgium 102 82 (80%) 23.6 51.8 443.0 70 (69%) 27 (26%) 2 (2%) 3 (3%)
Denmark 101 78 (77%) 18.9 40.3 409.3 33 (33%) 63 (62%) 4 (4%) 1 (1%)
France 100 78 (78%) 19.9 51.2 453.4 44 (44%) 45 (45%) 3 (3%) 8 (8%)
germany 100 64 (64%) 18.8 46.9 520.6 57 (57%) 41 (41%) 0 2 (2%)
ireland 101 62 (61%) 18.3 36.0 382.6 36 (36%) 58 (57%) 7 (7%) 0
italy 100 82 (82%) 24.6 34.9 390.6 59 (59%) 29 (29%) 7 (7%) 5 (5%)
The Netherlands 100 77 (77%) 19.8 38.6 529.9 28 (28%) 64 (64%) 6 (6%) 2 (2%)
Norway 100 72 (72%) 16.9 35.0 331.6 13 (13%) 65 (65%) 18 (18%) 4 (4%)
Poland 100 61 (61%) 16.7 38.0 589.4 24 (24%) 71 (71%) 1 (1%) 4 (4%)
Portugal 100 60 (60%) 22.3 42.9 399.3 9 (9%) 30 (30%) 50 (50%) 11 (11%)
Spain 101 81 (80%) 21.1 37.6 575.2 11 (11%) 32 (32%) 50 (50%) 8 (8%)
Sweden 100 68 (68%) 18.3 35.0 242.3 2 (2%) 52 (52%) 42 (42%) 4 (4%)
UK 104 84 (81%) 16.7 38.0 470.5 5 (5%) 61 (59%) 33 (32%) 5 (5%)
Abbreviations: MDT, multidisciplinary team; PCP, primary care physician.
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the minority (n = 57) stating that they worked within a 
large multidisciplinary team (definition not given) com-
pared with other practices (77% vs 87%–90%), and in 
those from  Portugal (81% vs $91% of respondents in 
the UK, Sweden, and Ireland). On average, the PCPs 
surveyed perceived CNMP to be a low priority within 
the healthcare system, despite the challenges it poses 
(Figure 1). Regardless of sex, length of experience, 
and practice size, 79% of PCPs stated that the manage-
ment of CNMP should be higher on the government 
health agenda; this view was particularly prevalent in 
Italy, France, Poland, Spain, and Portugal (88%–91%) 
compared with the Netherlands and Denmark (#55%). 
Nearly three-quarters of respondents (74%) stated that 
chronic pain should be considered a disease in its own 
right (ranging from 56% of those in Denmark to 94% of 
those in Italy), though 57% considered that chronic pain 
is more a symptom than a condition (ranging from 42% 
in Germany and 43% in Italy to 70% in the Netherlands 
and 71% in Sweden).
Pain assessment
Fewer than half (48%) of the PCPs used pain assessment 
tools (Table 2); this was significantly lower among those 
practicing for $31 years (31%) compared with physicians 
in practice for 6–20 years (52%–60%) (P , 0.05). Pain 
assessment tools were used by 70% of doctors stating that 
they worked in a large multidisciplinary team (not defined), 
compared with 43%–49% of practitioners in other practices 
(P , 0.05). Among respondents using assessment tools 
(n = 628), the most commonly used were visual analogue 
scales (mentioned by 64%) and numerical rating scales 
(51%). Although the majority (83%) of those using assess-
ment tools recorded the results in the patients’ notes, this 
corresponded to just 40% of all PCPs surveyed.
High priority
6
Cardiovascular diseases
Cancers
Diabetes
Low
challenge
High
challenge
Low priorityMean ranking score
Respiratory
disorders
Mental illness
Chronic non-malignant pain
5
4
6543
2
1
321
Figure 1 PCP perceptions of CNMP compared with other chronic conditions.
Abbreviations: CNMP, chronic nonmalignant pain; PCP, primary care physician.
Among those not using assessment tools, the main rea-
son given was lack of knowledge (26%); this was a greater 
problem for those with many years of practice (40% of 
those in practice for $31 years vs 12% for #5 years). Other 
reasons given included the view that tools were not useful 
(18%), the lack of time (16%), the preference “to just talk 
with the patient” (13%), and the view that these were too 
impersonal (12%).
Overall, 81% of PCPs surveyed believed that chronic pain 
and its impact on quality of life is underassessed in primary 
care. Fewer than half (49%) of the PCPs reported having 
adequate time in their consultations with patients to discuss 
pain and its management, and only 64% felt they had adequate 
tools for the diagnosis and management of CNMP.
Opioids
Of the patients with CNMP seen by the respondents, 40% 
were managed without use of opioids, 40% used weak opioids 
only (commonly used for the management of mild to moder-
ate pain), 11% used strong opioids only (commonly used for 
the management of moderately severe to severe pain), and 
9% used both strong and weak opioids. PCPs were generally 
confident about prescribing opioids for cancer pain but less 
 confident about opioid use in CNMP (Figure 2). Confidence 
was particularly low in Norway, Sweden, and Poland, with 46%, 
43%, and 37%, respectively, reporting a lack of confidence in 
the use of strong opioids for CNMP compared with #20% 
in the UK, the Netherlands, France, and Italy. Among the 
304 PCPs who were very confident using strong opioids for 
CNMP, the most common reasons given were experience 
(mentioned by 34%) and available treatments (33% overall, 
Table 2 Use of assessment tools
Country N % PCPs  
using tools
% PCPs using tools but 
not recording in notes
Total 1309 48 17
Belgium 102 42 23
Denmark 101 36 19
France 100 60 15
germany 100 59 12
ireland 101 37 8
italy 100 39 28
The Netherlands 100 42 10
Norway 100 63 5
Poland 100 65 22
Portugal 100 48 38
Spain 101 52 11
Sweden 100 56 16
UK 104 26 22
Abbreviation: PCP, primary care physician.
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with 70% in practitioners with #5 years of  experience 
vs 22%–40% in those practicing for longer). Among the 
92 PCPs who were not confident at all about using strong 
 opioids in CNMP, the main reasons given were concerns 
about addiction or abuse (35%) and adverse events (22%).
The majority of PCPs (86%) reported that constipation 
was the side effect of strong opioids most commonly raised as 
an issue by patients (Figure 3); there was significantly lower 
reported concern about constipation in Portugal (56%) than 
in all other countries (P , 0.05).
Educational needs
Overall, 84% of PCPs reported that their initial training in 
CNMP management was not comprehensive. More respon-
dents from the UK, Belgium, Poland, and the Netherlands 
were dissatisfied with their initial training (88%–91%) than 
those in France, Germany, and Ireland (72%–78%).  During 
the preceding year, 75% of respondents had received formal 
training and education on CNMP management, with a lower 
proportion in Sweden (42%) than in all other countries 
and $92% in Italy, Spain, and Poland. This training was for an 
average of 10 hours and was significantly lower (#5 hours) in 
UK, France, Sweden, Belgium, the Netherlands, and  Ireland 
compared with $20 hours in Italy and Spain (P , 0.05). 
The main reason given by the 332 respondents who had not 
received such training during the last year was lack of time 
(mentioned by 70%). Most PCPs (89%) surveyed perceived 
a need for more education on CNMP management.
Guidelines for pain management appear to be used 
more commonly for cancer pain than for CNMP (Figure 4). 
There are no universal guidelines for the management of 
CNMP, though 72% of respondents reported that these were 
required. This view was significantly more prevalent in 
women (76% vs 70% in men) (P , 0.05), recently qualified 
doctors (79%–83% of PCPs with #10 years experience vs 
63%–67% of PCPs with $26 years experience), and those 
working with other PCPs and in multidisciplinary teams 
(73%–84% vs 62% of single practitioners). There were also 
considerable differences between countries, ranging from 
96% and 91% in Spain and Poland, respectively, to 57% in 
France and Italy.
Discussion
This large survey showed that PCPs in Europe, like their 
counterparts in North America, find the primary care man-
agement of CNMP a considerable challenge.3,5,7,9 Fewer than 
half of the PCPs across Europe used pain assessment tools, 
and the majority of respondents recognized that chronic pain 
and its impact on quality of life are under-assessed in pri-
mary care. There was some lack of confidence in prescribing 
strong opioids for CNMP. Overall, 89% of PCPs perceived 
a need for more education on chronic pain, and there was 
considerable demand for clinical guidelines focused on the 
management of CNMP.
The study has a number of limitations. Because of the 
online-survey format, respondents were self-selected, though 
Chronic non-malignant pain
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Not very
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Chronic cancer pain
Weak opioids Strong opioids
Figure 2 Proportion of PCPs (% [n = 1305]) reporting confidence in prescribing 
opioids for chronic pain.
Abbreviation: PCP, primary care physician.
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Figure 3 Side-effects of strong opioids reported by PCPs as most commonly raised 
by patients.
Abbreviation: PCP, primary care physician.
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Figure 4 Proportion of PCPs (% [n = 1305]) reporting use of guidelines for 
chronic pain.
Abbreviation: PCP, primary care physician.
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representative of the PCP population within each country. 
Respondents were drawn from 13 countries, each with its own 
healthcare system, so there was considerable heterogeneity 
in terms of the size of primary care practices and the number 
of patients seen by each physician, although this approach 
ensured the results reflected the broad European situation. It 
should be noted that the overall findings of this survey were 
consistent with those of other approaches (eg, postal surveys, 
discussion groups) used in other surveys of PCPs.8,9,11 As with 
other surveys, time and size constraints of the study meant 
that related topics (eg, attitudes towards nonpharmacological 
management of pain) could not be considered.
The survey found a lack of clear guidelines for the 
assessment and management of CNMP (or lack of  awareness 
of such guidelines). Although CNMP was seen by the 
 majority of PCPs as a condition in its own right, guide-
lines on pain management may be fragmented – there are 
multiple guidelines for specific conditions (eg, headache, 
musculoskeletal conditions) that have chronic pain as a 
symptom. The numerous gaps in evidence may contribute 
to the lack of appropriate guidelines, and there is a need for 
further research in the management of CNMP.12 A recent 
review of the evidence available to guide the management 
of chronic pain in primary care, and other surveys of PCPs, 
also identified a lack of CNMP guidelines for the primary 
care setting.11,13 There appears to be an important potential 
role for professional organizations in developing and dis-
seminating European guidelines for the management of 
CNMP in primary care.
Despite the recognized importance of formal evaluation 
to guide treatment and assess response,14 the survey found 
that over half the PCPs did not use tools to assess CNMP, 
primarily due to lack of knowledge, particularly amongst 
PCPs who have been in practice for many years. This situa-
tion could be addressed by improved education. There may 
also be a need for improved assessment tools, consistent 
with findings from PCPs in the USA.15 In another survey, 
PCPs reported a mean of 2.3 minutes spent on discussions 
about pain during their consultations with elderly patients 
and concluded that time constraints adversely affected pain 
management,16 suggesting that assessment tools should be 
quick and easy to use.
While short-term studies have established the clinical 
effectiveness of opioids for CNMP, evidence on long-term use 
remains limited.12 The survey found that 40% of the patients 
seen by the PCPs did not use any opioids for the manage-
ment of CNMP, while one in five (20%) were managed using 
strong opioids (presumably for moderately severe to severe 
pain). Although almost two-thirds of respondents (64%) 
were fairly or very confident in the use of strong opioids for 
CNMP, more than a quarter of respondents (27%) showed 
some lack of confidence. Similar findings have been reported 
in other studies,3,5,15 including one US study that found 71% 
of PCPs felt moderately or strongly confident of their ability 
to treat chronic pain.7
The pan-European survey reported here and others have 
found PCPs are concerned about the potential for opioid 
addiction or misuse.17,18 A study of PCPs in the USA found 
that although most respondents believed it lawful and appro-
priate to use opioids for cancer pain, fewer than half held this 
view for CNMP;9 that study and others found widespread 
concerns that PCPs using such treatment could become 
the subject of investigation.8,19,20 Such US experiences and 
concerns may influence European PCPs.
The survey suggested some concern among PCPs about 
the potential for side effects from opioids. In a survey of 
PCPs in Canada, 42% reported that patients using opioids 
for CNMP had experienced at least one adverse event during 
the preceding year.8 According to the present study, consti-
pation is the side effect of strong opioids most commonly 
raised as an issue by patients, consistent with other studies 
showing the high frequency of opioid-related bowel dysfunc-
tion in patients receiving treatment for chronic pain.21–23 The 
OMPC may be able to address the need for education to 
improve patient selection for opioid treatment and subsequent 
monitoring, and to disseminate information about minimizing 
opioid-related bowel dysfunction.
The survey found dissatisfaction with education on 
CNMP management, consistent with the findings of other 
studies. Despite pain being a common reason for primary care 
consultation,18,24 education about pain represents less than 1% 
of university-based teaching for healthcare professionals.25 
In a study of medical undergraduates, most held negative 
views about pain management, particularly regarding chronic 
pain;24 medical students also experience considerable anxiety 
about encounters with patients suffering from chronic pain.26 
Training on pain should address interviewing skills as well 
as knowledge of pain mechanisms.27
Conclusion
This large survey conducted in 13 European countries has 
shown that PCPs find CNMP a challenge to treat. Training 
in the use of assessment tools and the appropriate prescrip-
tion of strong opioids, and the development of guidelines 
on primary care CNMP management would be welcomed 
by European PCPs. These findings should provide the basis 
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for future initiatives by the OMPC and other organizations 
to support primary care management of chronic pain in 
Europe.
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Supplementary material
OPENMinds Primary Care questionnaire
Section 1: Assessment
Q1. How many patients do you see in an average month?
Q2. Out of these patients, how many would suffer from 
non-malignant chronic pain in an average month?
Q3. Out of these non-malignant chronic pain patients, 
how many on aver age would be new patients and 
how many would be follow-up patients?
Q4. When managing your patients with chronic non-
malignant pain do you use any assessment scales/
tools?
Q5. As standard practice which assessment scales/tools do 
you use to assess pain in patients with non-malignant 
chronic pain?
Q6. Why do you not use any assessment scales/tools to 
assess pain in patients with non-malignant chronic 
pain?
Q7. Do you record the results of the assessment scales/
tools in the patients’ medical records?
Q8. Do you have access to a pain clinic to refer non-
malignant chronic pain patients to?
Q9. How many patients do you refer to a pain clinic in an 
average year?
Q10. What are your three most common reasons for refer-
ring these patients to a pain clinic? Please rank these 
three reasons in terms of how common they are.
Q11. Which of the following best describes your approach 
for following up with patients that you initiate on pain 
medication for the management of non-malignant 
chronic pain?
I ask the patient to return or seek advice if they do not 
respond to the treatment
I schedule a routine follow-up irrespective of the 
patient’s response to the therapy
I do not schedule a follow-up
Other – please specify
Q12. Which of the following best describes your approach 
for following up with patients that are receiving 
ongoing pain medication for the management of non-
malignant chronic pain?
I ask the patient to return or seek advice if they do not 
respond to the treatment
I schedule a routine follow-up irrespective of the 
patient’s response to the therapy
I do not schedule a follow-up
Other – please specify
Section 2: Education and guidelines
Q13. To what extent do you refer to guidelines for the man-
agement of patients with non-malignant chronic pain 
and for the management of patients with malignant 
pain?
Q14. Which guidelines for the management of patients with 
non-malignant chronic pain do you refer to?
Q15. To what extent do you think specific guidelines 
are required for the management of non-malignant 
chronic pain and for the management of malignant 
pain?
Q16. Please now think about the training you received 
during your medical course (pre-graduation). How 
compre hensive, if at all, was the training you received 
specific to the management of non-malignant chronic 
pain?
Q17. In the past year, how many hours have you spent on 
formal training (including accredited training) and 
educa tion specific to non-malignant chronic pain?
Q18. What would be your preferred formats of learning for 
non-malignant chronic pain today?
Q19. To what extent do you agree or disagree that more edu-
cation is required in the area of non-malignant chronic 
pain management for primary care physicians?
Q20. What has prevented you from undertaking additional 
training or education in the area of non-malignant 
chronic pain management?
Q21. What would motivate you to undertake additional 
training or education in the area of non-malignant 
chronic pain management?
Section 3: Policy
Q22. To what extent do you agree or disagree with each of 
the following statements?
Non-malignant chronic pain is one of the most chal-
lenging conditions to treat
Patients with non-malignant chronic pain are more 
challenging to manage than the typical patient
I have adequate tools to diagnose and manage patients 
with non-malignant chronic pain
I have adequate time in my consultations to discuss 
non-malignant chronic pain with patients
The management of non-malignant chronic pain 
should be higher on the government’s health agenda
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Chronic pain should be considered as a disease in its 
own right
Chronic pain is more of a symptom than a condition
Chronic pain and its impact on quality of life tends to 
be under-assessed in primary care
Apart from the duration of pain, there are no differ-
ences between chronic pain and acute pain
Q23. Which one of the following statements do you most 
agree with?
Chronic pain is definitely a medical symptom
Chronic pain is more a medical symptom than a psy-
chological symptom
Chronic pain is a medical and psychological 
symptom
Chronic pain is more a psychological symptom than 
a medical symptom
Chronic pain is definitely a psychological symptom
Q24. In your opinion, how much of a challenge is posed 
by each of the following in terms of treatment?
Non-malignant chronic pain
Respiratory disorders
Cardiovascular diseases
Mental illness
Cancers
Diabetes
Q25. In your opinion, how much of a priority are each of the 
following conditions within the healthcare system?
Non-malignant chronic pain
Respiratory disorders
Cardiovascular diseases
Mental illness
Cancers
Diabetes
Section 4: Opioid usage
Q26. Are special prescription forms needed to prescribe 
weak and/or strong opioids?
Q27. How easy or difficult is it for you to write weak 
and/or strong opioids prescriptions using these 
forms?
Q28. Please rank opioids in terms of their strength/
potency.
Q29. How many of the patients with non-malignant chronic 
pain that you see in a typical month are managed with 
opioids?
Q30. How confident, if at all, are you in prescribing opioids 
for non-malignant chronic pain patients and for malig-
nant pain patients?
Q31. Why do you say that you have this confidence in 
prescrib ing strong opioids for non-malignant chronic 
pain patients?
Q32. Which of the following best describes your approach 
for following up with patients that you initiate on 
strong opioids for management of non-malignant 
chronic pain?
I ask the patient to return or seek advice if they do not 
respond to the treatment
I schedule a routine follow-up irrespective of the 
patient’s response to the therapy
I do not schedule a follow-up
I do not initiate strong opioids
Other – please specify
Q33. Which of the following are your key reasons for 
not initiating the prescription of strong opioids to 
patients for the management of non-malignant chronic 
pain?
Patients’ pain is not severe enough
Difficulty identifying appropriate patients
Concerns over dependency/addiction
Price
Lack of reimbursement
Lack of guidelines
It is not available by law
Side effects
Patients don’t want to be treated with strong opioids
Lack of confidence/understanding of strong opioids
Controlled drug status
Other – please specify
None of the above
Q34. To what extent, if at all, does each of the following 
influence your decision to prescribe strong opioids to 
a patient?
Patient’s ability to drive while taking strong opioids
Patient’s ability to work
Patient’s ability to perform household tasks
Patient’s ability to look after children and/or family
I do not prescribe strong opioids
Q35. How frequently, on average, would you ask these 
patients on strong opioids to return for a routine 
follow-up after initiating them on the treatment?
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Q36. What are the 3 most important factors you take into 
account when initiating a patient on strong opioid 
therapy for management of non-malignant chronic 
pain? Please rank these three factors in terms of how 
important they are.
Q37. How important, if at all, are the following when con-
sidering initiating treatment of strong opioid therapy 
for management of non-malignant chronic pain?
Reduction in pain (efficacy)
Improvement in functioning
Side effects
Quality of life
Q38. Which one of the following would you say is the most 
important factor when considering initiating treatment 
of a patient on strong opioid therapy for management 
of non-malignant chronic pain, above all others?
Reduction in pain (efficacy)
Improvement in functioning
Side effects
Quality of life
Q39. Which three side effects do patients prescribed strong 
opioids most commonly raise as an issue?
Q40. Please rank these three side effects you have selected, 
in terms of how frequently they are raised as an issue 
by patients.
Q41. And finally, in your opinion please rank these three 
side effects you have selected, in terms of how difficult 
they are to treat.
Q42. In light of the topics covered today, what else would 
you like to add?
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